Carmat SA (EPA:ALCAR)
France
· Delayed Price · Currency is EUR 0.7991
+0.0111 (1.41%)
May 12, 2025, 5:35 PM CET
Carmat Revenue
In the year 2024, Carmat had annual revenue of 7.00M EUR with 82.43% growth. Carmat had revenue of 3.35M in the half year ending December 31, 2024, with 854.99% growth.
Revenue
7.00M
Revenue Growth
+82.43%
P/S Ratio
6.71
Revenue / Employee
43.21K
Employees
200
Market Cap
47.00M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 7.00M | 3.16M | 82.43% |
| Dec 31, 2023 | 3.84M | 3.36M | 704.40% |
| Dec 31, 2022 | 477.00K | -1.76M | -78.68% |
| Dec 31, 2021 | 2.24M | 2.23M | 24,755.56% |
| Dec 31, 2020 | 9.00K | -5.00K | -35.71% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Sanofi | 45.17B |
| EssilorLuxottica Société anonyme | 26.51B |
| Sartorius Stedim Biotech | 2.86B |
| bioMérieux | 3.98B |
| Eurofins Scientific SE | 6.95B |
| Ipsen | 3.57B |
| Virbac | 1.40B |
| emeis Société anonyme | 5.64B |